Letter to the Editor
Results from phase II, open-label study of anti-tumoral activity of first-line erlotinib in advanced/metastatic NSCLC patients with EGFR activating mutations, in Portugal: The MuTAR study
F. Barataa, H. Queirogab, E. Teixeirac, T. Almodovard, M. Soarese, B. Parentef, J.C. Mellidezg, P. Alvesc, A. Antunesh,
Corresponding author
a Centro Hospitalar e Universitário de Coimbra, Portugal
b Centro Hospitalar São João, Porto, Portugal
c Centro Hospitalar Lisboa Norte, Lisboa, Portugal
d Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal
e Instituto Português de Oncologia Francisco Gentil, Porto, Portugal
f Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
g Centro Hospitalar Baixo Vouga, Aveiro, Portugal
h Roche Farmacêutica Química, Portugal
Read
5036
Timeswas read the article
2243
Total PDF
2793
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 5 | 11 |
| 2025 5 | 74 | 44 | 118 |
| 2025 4 | 73 | 39 | 112 |
| 2025 3 | 65 | 24 | 89 |
| 2025 2 | 42 | 29 | 71 |
| 2025 1 | 37 | 24 | 61 |
| 2024 12 | 23 | 34 | 57 |
| 2024 11 | 23 | 32 | 55 |
| 2024 10 | 33 | 32 | 65 |
| 2024 9 | 18 | 35 | 53 |
| 2024 8 | 51 | 50 | 101 |
| 2024 7 | 45 | 39 | 84 |
| 2024 6 | 45 | 29 | 74 |
| 2024 5 | 36 | 34 | 70 |
| 2024 4 | 42 | 41 | 83 |
| 2024 3 | 37 | 30 | 67 |
| 2024 2 | 41 | 22 | 63 |
| 2024 1 | 37 | 29 | 66 |
| 2023 12 | 13 | 22 | 35 |
| 2023 11 | 49 | 54 | 103 |
| 2023 10 | 35 | 30 | 65 |
| 2023 9 | 26 | 36 | 62 |
| 2023 8 | 24 | 21 | 45 |
| 2023 7 | 21 | 33 | 54 |
| 2023 6 | 31 | 19 | 50 |
| 2023 5 | 40 | 28 | 68 |
| 2023 4 | 32 | 19 | 51 |
| 2023 3 | 61 | 26 | 87 |
| 2023 2 | 42 | 26 | 68 |
| 2023 1 | 30 | 22 | 52 |
| 2022 12 | 72 | 23 | 95 |
| 2022 11 | 50 | 44 | 94 |
| 2022 10 | 83 | 46 | 129 |
| 2022 9 | 43 | 44 | 87 |
| 2022 8 | 37 | 39 | 76 |
| 2022 7 | 40 | 55 | 95 |
| 2022 6 | 37 | 48 | 85 |
| 2022 5 | 38 | 41 | 79 |
| 2022 4 | 31 | 49 | 80 |
| 2022 3 | 37 | 48 | 85 |
| 2022 2 | 45 | 46 | 91 |
| 2022 1 | 65 | 67 | 132 |
| 2021 12 | 32 | 41 | 73 |
| 2021 11 | 45 | 36 | 81 |
| 2021 10 | 42 | 53 | 95 |
| 2021 9 | 42 | 38 | 80 |
| 2021 8 | 43 | 36 | 79 |
| 2021 7 | 39 | 32 | 71 |
| 2021 6 | 50 | 46 | 96 |
| 2021 5 | 33 | 54 | 87 |
| 2021 4 | 210 | 178 | 388 |
| 2021 3 | 86 | 64 | 150 |
| 2021 2 | 82 | 71 | 153 |
| 2021 1 | 43 | 29 | 72 |
| 2020 12 | 40 | 18 | 58 |
| 2020 11 | 54 | 25 | 79 |
| 2020 10 | 146 | 37 | 183 |
| 2020 9 | 96 | 27 | 123 |
Show all
